May 17, 2018, Thursday
The stock rallied 7% to Rs 104 after the company said Granules Pharmaceuticals Inc., a wholly owned subsidiary of the company, ...
February 20, 2017, Monday
Investment will be backed by IFC, which has three previous exposures to the company
January 09, 2017, Monday
The regulator had detected nonconformities in the good manufacturing practices system
January 09, 2017, Monday
The stock dipped nearly 11% to Rs 97.80 on BSE in early morning trade on back of heavy volumes
October 25, 2016, Tuesday
The company's revenues stood at Rs 363.81 crore, an increase of 3% over Rs 352.9 crore in the year ago period
October 13, 2016, Thursday
Shares of Granules India Ltd were trading 0.62 per cent higher at Rs 121 on BSE
August 11, 2016, Thursday
Total income from operations grew 6.56% to Rs 343.73 crore in the quarter from Rs 322.56 crore in the year ago period
July 14, 2016, Thursday
The company did not disclose the details about exact payout being made towards this stake buy, citing confidentiality agreement
June 09, 2016, Thursday
The company's US arm has exclusive agreement with USpharma Windlas, LLC for product in-licensing
June 09, 2016, Thursday
Windlas through its subsidiaries holds Abbreviated New Drug Applications (ANDAs) for Fingolimod, Prasugrel, Dronedarone and ...
